Jeff Yass’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
Other funds holding KROS
Jeff Yass's KROS Position: Q3 2026 in Review
Jeff Yass increased its Keros Therapeutics (KROS) stake by 32% in Q3 2026, buying an estimated $74.2K and bringing the position to 27,828 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #10838.
Jeff Yass first reported a position in KROS in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.43M in Q3 2025. 135 funds tracked by Wall St. Rank hold KROS as of Q3 2026.
- Jeff Yass held 27,828 shares of Keros Therapeutics worth $317K as of Q3 2026.
- Jeff Yass bought 6,785 Keros Therapeutics shares in Q3 2026, an estimated $74.2K.
- Keros Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10838 holding.
- Jeff Yass first reported a position in Keros Therapeutics in Q4 2020 and has held it in 21 quarters since.
- Jeff Yass's Keros Therapeutics position peaked at $3.43M in Q3 2025.
- 135 funds tracked by Wall St. Rank held Keros Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.